ScienceMed®

Effect of probiotic-derived metabolites on hormonal and metabolic profiles in women with polycystic ovary syndrome: a systematic review and meta-analysis

Endocrinologia

MetanáliseNível 1 · Evidência consolidadaFrontiers in cellular and infection microbiology19 nov 20257 citações

Salvar

Resumo original em inglês

O que aconteceu

Polycystic ovary syndrome (PCOS) is a common endocrine-metabolic disorder linked to insulin resistance and hyperandrogenism. Gut microbiota-derived metabolites, including short-chain fatty acids (SCFAs), indoles, and bile acids, influence endocrine and metabolic pathways. Yet, no systematic review has specifically examined metabolite-targeted interventions in PCOS.

To assess the effects of probiotic-derived metabolite interventions on hormonal and metabolic outcomes in women with PCOS.

Following PRISMA 2020 and a PROSPERO-registered protocol (CRD42025543210), we searched MEDLINE, Embase, Web of Science, Scopus, Cochrane CENTRAL, and two Chinese databases to May 2025 without language restrictions. Eligible studies were randomized or quasi-randomized controlled trials ≥8 weeks. Two reviewers independently screened, extracted data, and assessed risk of bias (RoB 2). Pooled analyses used random-effects models, and evidence certainty was appraised with GRADE.

https://www.crd.york.ac.uk/prospero/, identifier CRD42025543210.

O que encontraram

Seventeen trials (n = 1, 214 women) were included, testing synbiotics (6), probiotics (7), sodium butyrate (2), Akkermansia muciniphila (1), and an SCFA blend (1). Interventions significantly reduced total testosterone (MD -0.19 ng/mL, 95% CI -0.30 to -0.08), LH/FSH ratio (SMD -0.46; 95% CI -0.66 to -0.26), fasting insulin (MD -2.4 µIU/mL; 95% CI -3.9 to -0.9), and HOMA-IR (MD -0.49; 95% CI -0.78 to -0.19). HDL-C increased modestly (MD + 3.2 mg/dL; 95% CI + 0.7 to +5.6). Evidence certainty was moderate for insulin-related outcomes and low for sex-hormone outcomes.

Por que isso importa

STargeting gut-derived metabolites, particularly with sodium butyrate and multi-strain synbiotics, improves hormonal and metabolic markers in PCOS. Larger multicenter RCTs with metabolomic confirmation are warranted to establish clinical translation.

Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.

O estudo original

Effect of probiotic-derived metabolites on hormonal and metabolic profiles in women with polycystic ovary syndrome: a systematic review and meta-analysis

Maneesh Kumar Maddirevula, Vinod Kumar Nelson, Mohamed Soliman, Bader Khalid Alanazi, Ahmed M S Hegazy, Habeeb Ali Baig, Amro M Soliman, Mansour Alanazi

Descritores MeSH

  • Hormones
  • Probiotics
  • Metabolome
  • Polycystic Ovary Syndrome
  • Randomized Controlled Trials as Topic
  • Gastrointestinal Microbiome
  • Synbiotics
  • Fatty Acids, Volatile
  • Female
  • Humans

Veja também